<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Xinru Qiu - Highlighted Projects</title>
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        body {
            font-family: 'Lato', sans-serif;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            line-height: 1.6;
            color: #333;
            margin: 0;
            padding: 0;
        }
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        .navbar {
            background-color: #ffffff;
            border-bottom: 1px solid #e7e7e7;
            padding: 10px 0;
            position: sticky;
            top: 0;
            z-index: 1000;
        }
        .navbar-nav {
            list-style-type: none;
            padding: 0;
            margin: 0;
            display: flex;
            justify-content: center;
        }
        .navbar-nav li {
            margin: 0 15px;
        }
        .navbar-nav a {
            color: #666666;
            text-decoration: none;
            font-weight: bold;
            font-size: 18px;
        }
        h1, h2, h3, h4 {
            color: #1a5f7a;
        }
        main {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        .paper {
            background-color: #ffffff;
            border-radius: 8px;
            box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
            margin-bottom: 30px;
            padding: 20px;
        }
        .paper-title {
            font-size: 1.5em;
            margin-bottom: 10px;
        }
        .paper-links {
            margin-bottom: 20px;
        }
        .button {
            display: inline-block;
            padding: 8px 16px;
            margin-right: 10px;
            background-color: #1a5f7a;
            color: #ffffff;
            text-decoration: none;
            border-radius: 4px;
            font-size: 14px;
        }
        .paper-details {
            display: flex;
            flex-wrap: wrap;
            gap: 20px;
        }
        .paper-figure {
            width: 300px;
            height: 300px;
            object-fit: cover;
            border-radius: 8px;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .paper-content {
            flex: 1;
            min-width: 300px;
        }
        footer {
            text-align: center;
            padding: 20px;
            background-color: #f5f7fa;
            margin-top: 40px;
        }
    </style>
</head>
<body>
    <nav class="navbar">
        <div class="container">
            <ul class="navbar-nav">
                <li><a href="/">Home</a></li>
                <li><a href="/publication/">Research</a></li>
                <li><a href="/talk/">Talks</a></li>
                <li><a href="/teaching/">Teaching</a></li>
                <li><a href="/misc/">Misc.</a></li>
            </ul>
        </div>
    </nav>

    <main>
        <h1>Highlighted Projects</h1>

        <div class="paper">
            <h2 class="paper-title">Deciphering Abnormal Platelet Subpopulations in COVID-19, Sepsis and Systemic Lupus Erythematosus through Machine Learning and Single-Cell Transcriptomics</h2>
            <p>Qiu, Xinru, Meera G. Nair, Lukasz Jaroszewski, and Adam Godzik</p>
            <p>2024</p>

            <div class="paper-links">
                <a href="https://www.mdpi.com/1422-0067/25/11/5941" class="button">ðŸ“„ Read Paper</a>
                <a href="https://github.com/xqiu625/PlateletSubpop-ML-ScTranscriptomics" class="button">ðŸ’» Code</a>
                <a href="https://www.mdpi.com/journal/ijms" class="button">Journal</a>
            </div>

            <div class="paper-details">
                <img src="platelet.jpeg" class="paper-figure">
                <div class="paper-content">
                    <h3>Key Findings:</h3>
                    <ul>
                        <li>Platelet-to-T cell ratio (Pla-T ratio) is a strong predictor of patient survival.</li>
                        <li>Platelets play a role in lymphocyte activation, proliferation, and differentiation.</li>
                        <li>Platelet-monocyte aggregation is associated with disease severity in both COVID-19 and sepsis.</li>
                        <li>We identified distinct platelet subpopulations that were overrepresented in convalescent, surviving, and fatal patients.</li>
                        <li>Notably, three types of platelets were highly represented in patients with fatal outcomes: a coagulation cluster (C4), a hypoxic cluster (C9), a quiescent cluster (C11).</li>
                    </ul>

                    <h3>Implications:</h3>
                    <ul>
                        <li>Monitoring changes in the Pla-T ratio and platelet subpopulations could be valuable for predicting patient outcomes and guiding treatment decisions.</li>
                        <li>Understanding the interplay between platelets and other immune cells may pave the way for therapies that modulate the immune response and improve patient outcomes.</li>
                        <li>Targeting heparanase activity, which is increased in platelets during sepsis and COVID-19, could be a promising therapeutic strategy.</li>
                    </ul>

                    <h3>Bioinformatics Approaches:</h3>
                    <ul>
                        <li>scRNA-seq Data Integration: Combined 413 samples from COVID-19, sepsis, SLE, and healthy individuals</li>
                        <li>Focus on Platelets: Extracted platelet expression data from PBMC datasets</li>
                        <li>Quality Control and Preprocessing: Used source data annotations, HGNChelper tool, and Harmony software</li>
                        <li>Cell Type Identification and Clustering: Used Seurat, SingleR, and Louvain Clustering algorithm</li>
                        <li>Differential Gene Expression Analysis: Employed MAST method from Seurat</li>
                        <li>Machine Learning: Used XGB and DNN for biomarker identification and feature importance</li>
                        <li>Pathway and Gene Set Enrichment Analysis: Used clusterProfiler, AddModuleScore, DOSE, and GSVA packages</li>
                        <li>Ligand-Receptor Interaction Analysis: Based on iTALK database</li>
                        <li>Pseudotime Trajectory Inference: Constructed using Monocle3</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Dynamic changes in human single-cell transcriptional signatures during fatal sepsis</h2>
            <p>Qiu, Xinru, Jiang Li, Jeff Bonenfant, Lukasz Jaroszewski, Aarti Mittal, Walter Klein, Adam Godzik, and Meera G. Nair</p>
            <p>2021</p>

            <div class="paper-links">
                <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629881/" class="button">ðŸ“„ Read Paper</a>
                <a href="#" class="button">ðŸ’» Code</a>
                <a href="https://jlb.onlinelibrary.wiley.com/" class="button">Journal</a>
            </div>

            <div class="paper-details">
                <img src="sepsis.png" class="paper-figure">
                <div class="paper-content">
                    <h3>Key Findings:</h3>
                    <ul>
                        <li>Lymphocyte subsets are reduced in sepsis, especially in fatal outcomes.</li>
                        <li>Platelets and erythroid precursors emerge in late-stage fatal sepsis.</li>
                        <li>Sepsis drives hypoxic stress associated with disease severity and dysfunctional erythropoiesis.</li>
                        <li>Monocytes in fatal sepsis undergo immune suppression.</li>
                        <li>Increased CD52 expression within hours of sepsis recognition is associated with improved sepsis outcomes.</li>
                    </ul>

                    <h3>Implications:</h3>
                    <ul>
                        <li>Antiplatelet therapies may be beneficial for treating severe sepsis.</li>
                        <li>S100A9 may be a valuable biomarker to stratify sepsis severity.</li>
                        <li>CD52 may serve as both a biomarker for sepsis progression and a therapeutic target to promote immune homeostasis.</li>
                    </ul>

                    <h3>Bioinformatics Approaches:</h3>
                    <ul>
                        <li>Data Processing and Quality Control: Used Cell Ranger Software Suite</li>
                        <li>Data Integration and Batch Effect Removal: Utilized Seurat v.3</li>
                        <li>Dimensionality Reduction and Clustering: Performed using Seurat</li>
                        <li>Cell Type Annotation: Used a consensus-based approach combining information from canonical marker genes, SingleR, and scCATCH</li>
                        <li>Differential Gene Expression Analysis: Employed MAST method from Seurat</li>
                        <li>Pathway Enrichment Analysis: Conducted using clusterProfiler</li>
                        <li>Module Score Analysis: Calculated to assess expression of predefined gene sets</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="paper">
            <h2 class="paper-title">Advances in AI for Protein Structure Prediction: Implications for Cancer Drug Discovery and Development</h2>
            <p>Qiu, Xinru, Han Li, Greg Ver Steeg, and Adam Godzik</p>
            <p>2024</p>

            <div class="paper-links">
                <a href="https://www.mdpi.com/2218-273X/14/3/339" class="button">ðŸ“„ Read Paper</a>
                <a href="https://www.mdpi.com/journal/biomolecules" class="button">Journal</a>
            </div>

            <div class="paper-details">
                <img src="ai_for_drug.jpeg" class="paper-figure">
                <div class="paper-content">
                    <h3>Key Findings:</h3>
                    <ul>
                        <li>AI is revolutionizing drug development, streamlining processes and increasing success rates.</li>
                        <li>Traditional drug development faces obstacles like high costs, long timelines, and high failure rates.</li>
                        <li>AI-driven protein structure prediction provides valuable insights for drug discovery.</li>
                        <li>Several AI algorithms offer distinct approaches to protein structure prediction:
                            <ul>
                                <li>AlphaFold2 (AF2): High accuracy, relies on multiple sequence alignments</li>
                                <li>ESMFold: Efficient for orphan proteins, faster than AF2</li>
                                <li>RoseTTAFold: Unique "three-track" neural network architecture</li>
                                <li>OpenFold: Open-source version of AF2, offers flexibility</li>
                            </ul>
                        </li>
                        <li>Generative AI is emerging as a powerful tool in drug development.</li>
                        <li>AI-driven drug discovery is demonstrating success beyond cancer research.</li>
                    </ul>

                    <h3>Implications:</h3>
                    <ul>
                        <li>Widespread adoption of AI could significantly alter the pharmaceutical landscape.</li>
                        <li>Understanding strengths and limitations of different AI algorithms is crucial for effective application.</li>
                        <li>Integration of AI necessitates careful consideration of data privacy, security, and validation procedures.</li>
                        <li>Continued research in AI algorithms is essential for maximizing impact in drug discovery.</li>
                        <li>AI-driven successes across diverse disease areas underscore potential to revolutionize healthcare.</li>
                    </ul>

                    <h3>Future Directions:</h3>
                    <ul>
                        <li>Develop AI algorithms for predicting protein dynamics and ligand-induced folding.</li>
                        <li>Expand applications of generative AI in designing novel proteins and antibodies.</li>
                        <li>Integrate AI-driven approaches with traditional drug discovery methods.</li>
                        <li>Address regulatory challenges posed by AI in pharmaceutical research.</li>
                        <li>Explore AI applications in personalized medicine and rare disease treatment.</li>
                    </ul>
                </div>
            </div>
        </div>
    </main>

    <footer>
        <p>Â© 2024 Xinru Qiu. All rights reserved.</p>
    </footer>
</body>
</html>
